Organ Specific Drug Delivery and Targeting to the Lungs (Organ-specific Drug Delivery and Targeting)

個数:

Organ Specific Drug Delivery and Targeting to the Lungs (Organ-specific Drug Delivery and Targeting)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 522 p.
  • 言語 ENG
  • 商品コード 9781032022529
  • DDC分類 615.1

Full Description

Organ Specific Drug Delivery and Targeting to the Lungs provides up to date information on the multidisciplinary field of particle engineering and drug delivery to the lungs, including advancements of nanotechnology. The text presents a unique, pragmatic focus with case studies, that help translate scientific understanding to practical implementation. In addition to highlighting the successful case studies, it also offers practical advice on watchouts, limitations, and 'bookend' boundaries involved in the stages of testing and development.

Additional Features Include:




Provides an account of particle engineering, discovery, biology, development, and delivery in relation with the advancements of nanotechnology, unlike any previous book.



Brings together the leading experts and researchers in the field to critically assess and discuss various topics influencing drug delivery.



Highlights the interplay of different scientific disciplines and the balance of requirements that are critical to molecule and product design.

With the strategic focus on what matters during new product development, this book provides a guide to understanding and navigating new drug discovery and development for lung targets.

Contents

Chapter 01

Estimating Clinically Relevant Measures of Inhaled Pharmaceutical Aerosol Performance with Advanced In Vitro and In Silico Methods

Chapter 02

In Vitro Assessment of Drug Release, Dissolution, and Absorption in the Lung

Chapter 03

Lung-on-a-Chip and Lung Organoid Models

Chapter 04

Interaction between Inhalable Nanomedicines and Pulmonary Surfactant

Chapter 05

Particle engineering for pulmonary drug delivery

Chapter 06

Particle Architectonics for Pulmonary Drug Delivery

Chapter 07

Engineered Particles for Aerosolisation and Lung Deposition

Chapter 08

Recent advances in inhalable nanomedicine for lung cancer therapy

Chapter 09

Thin-Film Freeze-Drying Process for Versatile Particles for Inhalation Drug Delivery

Chapter 10

Nanoparticles as specific drug carriers

Chapter 11

Surface modification of micronized drug particles for aerosolization

Chapter 12

Spray Dried Particles for Inhalation

Chapter 13

Inhalation Aerosol Phospholipid Particles for Targeted Lung Delivery

Chapter 14

Nebulizers

Chapter 15

Protein and Peptide Delivery to the Lung via Inhalation

Chapter 16

Exosomes Based Drug Delivery for Lung Cancer Treatment

最近チェックした商品